Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
about
Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.Closed-loop for type 1 diabetes - an introduction and appraisal for the generalist.Multivariable Adaptive Artificial Pancreas System in Type 1 Diabetes.The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel s12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.Targeting postprandial glycaemia in children with diabetes: Opportunities and challenges.Bolusing frequency and amount impacts glucose control during hybrid closed-loop.Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial.The artificial pancreas in 2017: The year of transition from research to clinical practice.Hypoglycaemia Incidence and Recovery During Home Use of Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin BolusesClosed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
P2860
Q33786175-EE8913C0-D072-4C87-A374-4250557529F5Q36258001-2BE7E875-5B07-47D1-A5FC-082E7D4C14FAQ38622678-85E26D25-0138-4938-819B-E61AB2B1A69CQ39413453-BA6ECC74-8730-4103-BB1E-C17FE32FF808Q39436182-394DC298-7D2E-482C-87B8-CB7EC069EC2EQ42696179-23EEA357-AB79-4A98-B763-197CCA9C5F0CQ47288459-1D8F30DB-7B35-4368-9070-32FDD11D9C4AQ48123950-E0E5E964-85F2-4D53-B534-1A29E6A930E3Q48326082-8EE4D770-FB2F-49F1-A191-2E0622EFA8F3Q48505370-2AFB3731-A33F-4A63-90D1-AE3A58A40212Q49501336-3B14DDBE-7614-4276-954F-117A63C0BCFCQ51734954-482CF224-FFAB-4093-8790-A95C6ADF3378Q53280517-5BED4261-86BF-4626-B2CA-B31F06603319Q55398504-A9DDBA8A-10E2-40F9-9834-CEF8195DFCF9Q56351163-A0990710-DFCA-470C-9BD3-6C949C022ACEQ57190370-D11F625E-EABC-400D-8812-E641218C72C7
P2860
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Day-and-night glycaemic contro ...... , randomised, crossover study.
@en
Day-and-night glycaemic contro ...... , randomised, crossover study.
@nl
type
label
Day-and-night glycaemic contro ...... , randomised, crossover study.
@en
Day-and-night glycaemic contro ...... , randomised, crossover study.
@nl
prefLabel
Day-and-night glycaemic contro ...... , randomised, crossover study.
@en
Day-and-night glycaemic contro ...... , randomised, crossover study.
@nl
P2093
P2860
P50
P1476
Day-and-night glycaemic contro ...... , randomised, crossover study.
@en
P2093
Harald Kojzar
Hood Thabit
Janet M Allen
Jehona Qerimi-Hyseni
Julia K Mader
Malgorzata E Wilinska
Sara Hartnell
Thomas R Pieber
P2860
P304
P356
10.1016/S2213-8587(17)30001-3
P577
2017-01-13T00:00:00Z